Back to Search Start Over

880P Phase II trial of the cyclin dependent kinase 4/6 inhibitor SHR6390 in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification

Authors :
C. Shi
J. Houyu
R. Zhou
Y. Wu
H. Li
Y. Wang
S. Xu
Z. Gu
J. Li
Z. Zhang
G. Ren
Source :
Annals of Oncology. 33:S950-S951
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Hematology

Details

ISSN :
09237534
Volume :
33
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........edcff3f8e72b65baff3404b983b72c47
Full Text :
https://doi.org/10.1016/j.annonc.2022.07.1006
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details